Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer
EOMI
2 other identifiers
interventional
52
1 country
1
Brief Summary
The aim of this clinical study is to investigate the extent to which ear acupuncture has an effect on insomnia in women with breast cancer. It will be investigated whether changes in sleep quality, fatigue, quality of life, stress, and psychological well-being can be achieved. In addition, a proinflammatory cytokine will be meassured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2019
CompletedFirst Posted
Study publicly available on registry
March 14, 2019
CompletedStudy Start
First participant enrolled
June 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2020
CompletedMay 24, 2021
May 1, 2021
8 months
March 13, 2019
May 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sleep Quality
Pittsburgh Sleep Quality Index (PSQI). The PSQI contains 19 self-assessment questions and 5 questions rated by the bed-partner or roommate. The 5 questions rated by the bed-partner or roommate are only used as clinical information and not included in qualitative analysis. The question whether a bed-partner or roommate is present is not included in qualitative analysis as well. The 18 self-assessment items are used to evaluate the sleep quality on 7 domains over the last month (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, and sleep disturbances, use of sleep medication, and daytime dysfunction). Scoring of the answers is based on a scale from 0 to 3, whereby 3 reflects the negative extreme on a Likert Scale. The total score is generated by the summation of the component scores and can vary from 0 to 21, with a higher score corresponding to a reduced sleep quality. A cut-off score of 5 indicates a "poor" sleeper.
week 0
Sleep Quality
Pittsburgh Sleep Quality Index (PSQI). The PSQI contains 19 self-assessment questions and 5 questions rated by the bed-partner or roommate. The 5 questions rated by the bed-partner or roommate are only used as clinical information and not included in qualitative analysis. The question whether a bed-partner or roommate is present is not included in qualitative analysis as well. The 18 self-assessment items are used to evaluate the sleep quality on 7 domains over the last month (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, and sleep disturbances, use of sleep medication, and daytime dysfunction). Scoring of the answers is based on a scale from 0 to 3, whereby 3 reflects the negative extreme on a Likert Scale. The total score is generated by the summation of the component scores and can vary from 0 to 21, with a higher score corresponding to a reduced sleep quality. A cut-off score of 5 indicates a "poor" sleeper.
week 5
Secondary Outcomes (23)
Quality of Life in cancer patients
week 0
Quality of Life in cancer patients
week 5
Quality of Life in cancer patients
week 17
Quality of Life in cancer patients
week 29
Fatigue
week 0
- +18 more secondary outcomes
Study Arms (2)
Ear acupuncture
EXPERIMENTALPsychoeducation
ACTIVE COMPARATORInterventions
Patients in the intervention group are treated twice a week for five weeks using semi-standardized ear acupuncture.
Patients of the control group receive a 1,5 h psychoeducation group concerning sleep improving behaviour.
Eligibility Criteria
You may qualify if:
- Histological diagnosed non-metastatic breast CAs (TNM stage I-III)
- Existing insomnia (difficulty falling asleep or sleeping through on at least 3 days per week for at least 3 months) according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM 5).
- willingness to participate in the study (at least 8 out of 10 treatments)
- Signed informed consent
You may not qualify if:
- Ongoing or planned chemotherapy, radiation, follow-up treatment or reconstructive plastic surgery during the study period
- Severe physical or psychopharmacologically treated psychiatric comorbidity that prevents a patient from participating in the study
- Pregnancy
- Participation in other clinical trials with behavioural, psychological or complementary medical interventions during the study period
- Regular use of barbiturates, antidepressants or other sleep-inducing drugs, drug abusus, alcoholism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universität Duisburg-Essenlead
- Karl and Veronica Carstens Foundationcollaborator
Study Sites (1)
Kliniken Essen-Mitte
Essen, North Rhine-Westphalia, 45276, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gustav Dobos, Prof. MD
University of Duisburg Essen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 13, 2019
First Posted
March 14, 2019
Study Start
June 12, 2019
Primary Completion
February 19, 2020
Study Completion
February 19, 2020
Last Updated
May 24, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share